Quality of life, long-term survivors and long-term outcome from the ABC-02 study.
Bridgewater, J Lopes, A Palmer, D Cunningham, D Anthoney, A Maraveyas, A Madhusudan, S Iveson, T Wasan, H
Bridgewater, J
Lopes, A
Palmer, D
Cunningham, D
Anthoney, A
Maraveyas, A
Madhusudan, S
Iveson, T
Wasan, H
Citations
Altmetric:
Abstract
The ABC-02 (Advanced Biliary Tract Cancer) study established cisplatin and gemcitabine (CisGem) as the standard first-line chemotherapy for patients with locally advanced or metastatic biliary tract cancer (BTC). We examine quality of life (QoL), describe the long-term survivors and provide a long-term outcome.
Affiliation
Description
Date
2016-04-26
Publisher
Collections
Keywords
Type
Article
Citation
Quality of life, long-term survivors and long-term outcome from the ABC-02 study. 2016, 114 (9):965-71 Br J Cancer